Indacaterol and Glycopyrrolate and Mogamulizumab
Determining the interaction of Indacaterol and Glycopyrrolate and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indacaterol and Glycopyrrolate-Mogamulizumab-kpkc
- Indacaterol and Glycopyrrolate-Mogamulizumab-kpkc Intravenous
- Indacaterol and Glycopyrrolate-Molindone
- Indacaterol and Glycopyrrolate-Mometasone (Oral Inhalation)
- Indacaterol and Glycopyrrolate-Mometasone and Formoterol
- Indacaterol and Glycopyrrolate-Mometasone and formoterol Inhalation
- Mogamulizumab-Indacaterol and glycopyrrolate Inhalation
- Mogamulizumab-Indacaterol inhalation
- Mogamulizumab-Indacaterol Maleate
- Mogamulizumab-Indapamide
- Mogamulizumab-Inderal
- Mogamulizumab-Inderal Intravenous